Mesoblast Limited (ASX:MSB)
Australia · Delayed Price · Currency is AUD 2.420
+0.070 (2.98%)
Feb 26, 2026, 2:19 PM AEST
Mesoblast Market Cap
Mesoblast has a market cap or net worth of 3.03 billion as of February 25, 2026. Its market cap has decreased by -17.64% in one year.
Market Cap
3.03B
Enterprise Value
2.98B
Revenue
26.23M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.42
Market Cap Chart
Since December 16, 2004, Mesoblast's market cap has increased from 76.57M to 3.03B, an increase of 3,861.59%. That is a compound annual growth rate of 18.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 3.03B | -13.08% |
| Dec 31, 2025 | 3.49B | -1.80% |
| Dec 31, 2024 | 3.55B | 1,029.56% |
| Dec 29, 2023 | 314.59M | -50.91% |
| Dec 30, 2022 | 640.82M | -29.87% |
| Dec 31, 2021 | 913.81M | -30.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Telix Pharmaceuticals | 3.06B |
| Neuren Pharmaceuticals | 1.61B |
| PYC Therapeutics | 1.40B |
| Clarity Pharmaceuticals | 1.40B |
| Opthea | 738.77M |
| Immutep | 567.38M |
| Clinuvel Pharmaceuticals | 563.25M |
| Racura Oncology | 425.10M |